Abstract: This medicament is useful for treatment and/or prevention of a cancer, said medicament containing a RET kinase inhibitor and an antibody or fragment thereof together or separately, said antibody or fragment thereof having immunological reactivity with a CAPRIN-1 protein.
| # | Name | Date |
|---|---|---|
| 1 | 202517008371-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [31-01-2025(online)].pdf | 2025-01-31 |
| 2 | 202517008371-STATEMENT OF UNDERTAKING (FORM 3) [31-01-2025(online)].pdf | 2025-01-31 |
| 4 | 202517008371-Sequence Listing in txt [31-01-2025(online)].txt | 2025-01-31 |
| 5 | 202517008371-Sequence Listing in PDF [31-01-2025(online)].pdf | 2025-01-31 |
| 6 | 202517008371-REQUEST FOR EXAMINATION (FORM-18) [31-01-2025(online)].pdf | 2025-01-31 |
| 7 | 202517008371-PROOF OF RIGHT [31-01-2025(online)].pdf | 2025-01-31 |
| 8 | 202517008371-POWER OF AUTHORITY [31-01-2025(online)].pdf | 2025-01-31 |
| 9 | 202517008371-FORM 18 [31-01-2025(online)].pdf | 2025-01-31 |
| 10 | 202517008371-FORM 1 [31-01-2025(online)].pdf | 2025-01-31 |
| 11 | 202517008371-FIGURE OF ABSTRACT [31-01-2025(online)].pdf | 2025-01-31 |
| 12 | 202517008371-DRAWINGS [31-01-2025(online)].pdf | 2025-01-31 |
| 13 | 202517008371-DECLARATION OF INVENTORSHIP (FORM 5) [31-01-2025(online)].pdf | 2025-01-31 |
| 14 | 202517008371-COMPLETE SPECIFICATION [31-01-2025(online)].pdf | 2025-01-31 |
| 15 | 202517008371-certified copy of translation [03-02-2025(online)].pdf | 2025-02-03 |
| 16 | 202517008371-MARKED COPIES OF AMENDEMENTS [08-02-2025(online)].pdf | 2025-02-08 |
| 17 | 202517008371-FORM 13 [08-02-2025(online)].pdf | 2025-02-08 |
| 18 | 202517008371-AMMENDED DOCUMENTS [08-02-2025(online)].pdf | 2025-02-08 |
| 19 | 202517008371-FORM 3 [23-07-2025(online)].pdf | 2025-07-23 |